Polymyxin B Combined with Minocycline: A Potentially Effective Combination against bla<sub>OXA-23</sub>-harboring CRAB in In Vitro PK/PD Model
Polymyxin-based combination therapy is commonly used to treat carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) infections. In the present study, the bactericidal effect of polymyxin B and minocycline combination was tested in three CRAB strains containing bla<sub>OXA-23&l...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/3/1085 |
Summary: | Polymyxin-based combination therapy is commonly used to treat carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) infections. In the present study, the bactericidal effect of polymyxin B and minocycline combination was tested in three CRAB strains containing bla<sub>OXA-23</sub> by the checkerboard assay and in vitro dynamic pharmacokinetics/pharmacodynamics (PK/PD) model. The combination showed synergistic or partial synergistic effect (fractional inhibitory concentration index ≤0.56) on the tested strains in checkboard assays. The antibacterial activity was enhanced in the combination group compared with either monotherapy in in vitro PK/PD model. The combination regimen (simultaneous infusion of 0.75 mg/kg polymyxin B and 100 mg minocycline via 2 h infusion) reduced bacterial colony counts by 0.9–3.5 log<sub>10</sub> colony forming units per milliliter (CFU/mL) compared with either drug alone at 24 h. In conclusion, 0.75 mg/kg polymyxin B combined with 100 mg minocycline via 2 h infusion could be a promising treatment option for CRAB bloodstream infections. |
---|---|
ISSN: | 1420-3049 |